Glaxo Sees More Competitive Shifts by U.S. Payers

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Feb. 5 (Bloomberg) -- Simon Dingemans, chief financial officer at GlaxoSmithKline Plc, discusses the drugmaker's growth, new products and maintaining competitiveness in the U.S. He speaks with Bloomberg's Makiko Kitamura in London. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change